Lilly pill trumps Humira in arthritis study
Wednesday, October 14, 2015 - 10:40
in Health & Medicine
(Reuters) - Eli Lilly and Co's experimental pill for rheumatoid arthritis proved superior to Abbvie Inc's leading injectable Humira treatment in a large study, which analysts said could prod them to raise sales forecasts for the medicine.